Tag: drug-eluting stents

paclitaxel

Without additional long-term and patient-level data, Katsanos et al’s conclusion is...

By Thomas Zeller The Katsanos et al meta-analysis reports an increased risk of mortality beyond one year across randomised studies of paclitaxel-coated balloons (DCB) and...

Deployable coating stents delivers drug more uniformly than traditional durable coated...

CBSET, a not-for-profit preclinical research institute dedicated to translational research, education, and advancement of medical technologies, has announced that its scientists have published data...

Angiolite BTK below-the-knee sirolimus-eluting stent receives CE mark approval

iVascular has announced the release of Angiolite BTK, a sirolimus-eluting stent which has received CE mark approval for treating chronic and acute arterial lesions in...

Cook launches 140mm Zilver PTX drug-eluting stent

Cook has extended its Zilver PTX product portfolio with a 140mm drug-eluting stent. Physicians will now be able to treat longer lesions with just...

Stefan Müller-Hülsbeck: The current drug-eluting stent landscape

In this interview, Stefan Müller-Hülsbeck, Diako Hospital, Flensburg, Germany, explains the implications of fresh two-year drug-eluting stent data from the MAJESTIC trial, and discusses...

Current status on drug-eluting devices in dialysis access

Dialysis access fistulae and grafts are life-saving in patients with renal insufficiency and failure. Numbers of patients requiring haemodialysis have continued to rise over...